Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study
Titel:
Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study
Auteur:
Krzeski, Piotr Buckland-Wright, Chris Bálint, Géza Cline, Gary A Stoner, Karen Lyon, Robert Beary, John Aronstein, William S Spector, Tim D